Role and mechanism of arsenic in regulating angiogenesis

PLoS ONE

Volumn 6, Issue 6, 2011, Pages

  Liu, Ling Zhi ^a   Jiang, Yue ^a   Carpenter, Richard L ^a   Jing, Yi ^a   Peiper, Stephen C ^a   Jiang, Bing Hua ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC; HYPOXIA INDUCIBLE FACTOR 1; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; VASCULOTROPIN; VASCULOTROPIN A;

ADENOCARCINOMA; ANGIOGENESIS; ARTICLE; CARCINOMA CELL; CELL IMMORTALIZATION; CONTROLLED STUDY; ENZYME ACTIVATION; GROWTH REGULATION; HUMAN; HUMAN CELL; LUNG ALVEOLUS CELL; LUNG ALVEOLUS EPITHELIUM; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; CHEMICALLY INDUCED DISORDER; CYTOLOGY; DRUG EFFECT; EPITHELIUM CELL; GENE EXPRESSION REGULATION; GENETICS; LUNG TUMOR; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); TIME; TUMOR CELL LINE; VASCULARIZATION;

ARSENIC; CELL LINE, TUMOR; ENZYME ACTIVATION; EPITHELIAL CELLS; GENE EXPRESSION REGULATION; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; LUNG NEOPLASMS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NEOVASCULARIZATION, PATHOLOGIC; PROTO-ONCOGENE PROTEINS C-AKT; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; TIME FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 79958153943     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0020858     Document Type: Article

References (45)

1. Brown LM, Pottern LM, Blot WJ, (1984) Lung cancer in relation to environmental pollutants emitted from industrial sources. Environ Res 34: 250-261.
2. Knobeloch LM, Zierold KM, Anderson HA, (2006) Association of arsenic-contaminated drinking-water with prevalence of skin cancer in Wisconsin's Fox River Valley. J Health Popul Nutr 24: 206-213.
3. Waalkes MP, Ward JM, Diwan BA, (2004) Induction of tumors of the liver, lung, ovary and adrenal in adult mice after brief maternal gestational exposure to inorganic arsenic: promotional effects of postnatal phorbol ester exposure on hepatic and pulmonary, but not dermal cancers. Carcinogenesis 25: 133-141.
4. Chowdhury R, Chatterjee R, Giri AK, Mandal C, Chaudhuri K, (2010) Arsenic-induced cell proliferation is associated with enhanced ROS generation, Erk signaling and CyclinA expression. Toxicol Lett 198: 263-271.
5. Davey JC, Bodwell JE, Gosse JA, Hamilton JW, (2007) Arsenic as an endocrine disruptor: effects of arsenic on estrogen receptor-mediated gene expression in vivo and in cell culture. Toxicol Sci 98: 75-86.
6. Dong JT, Luo XM, (1993) Arsenic-induced DNA-strand breaks associated with DNA-protein crosslinks in human fetal lung fibroblasts. Mutat Res 302: 97-102.
7. Reichard JF, Schnekenburger M, Puga A, (2007) A Long term low-dose arsenic exposure induces loss of DNA methylation. Biochem Biophys Res Commun 352: 188-192.
8. Shi H, Hudson LG, Ding W, Wang S, Cooper KL, et al. (2004) Arsenic causes DNA damage in keratinocytes via generation of hydroxyl radicals. Chem Res Toxicol 17: 871-878.
9. Li G, Lee LS, Li M, Tsao SW, Chiu JF, (2011) Molecular changes during arsenic-induced cell transformation. J Cell Physiol.
10. Huang C, Ke Q, Costa M, Shi X, (2004) Molecular mechanisms of arsenic carcinogenesis. Mol Cell Biochem 255: 57-66.
11. Ying S, Myers K, Bottomley S, Helleday T, Bryant HE, (2009) BRCA2-dependent homologous recombination is required for repair of Arsenic-induced replication lesions in mammalian cells. Nucleic Acids Res 37: 5105-5113.
12. Lee L, Bebb G, (2005) A case of Bowen's disease and small-cell lung carcinoma: long-term consequences of chronic arsenic exposure in Chinese traditional medicine. Environ Health Perspect 113: 207-210.
13. Neuberger JS, Field RW, (2003) Occupation and lung cancer in nonsmokers. Rev Environ Health 18: 251-267.
14. Guha Mazumder DN, (2007) Arsenic and non-malignant lung disease. J Environ Sci Health A Tox. Hazard Subst Environ Eng 42: 1859-1867.
15. Carmeliet P, Jain RK, (2000) Angiogenesis in cancer and other diseases. Nature 407: 249-257.
16. Folkman J, (1971) Tumor angiogenesis: therapeutic implications. N Engl J Med 285: 1182-1186.
17. Folkman J, (2006) Angiogenesis. Annu. Rev. Med 57: 1-18.
18. Voelkel NF, Douglas IS, Nicolls M, (2007) Angiogenesis in chronic lung disease. Chest 131: 874-879.
19. Walters EH, Reid D, Soltani A, Ward C, (2008) Angiogenesis: a potentially critical part of remodelling in chronic airway diseases? Pharmacol Ther 118: 128-137.
20. Gao N, Shen L, Zhang Z, Leonard SS, He H, et al. (2004) Arsenic induces HIF-1alpha and VEGF through PI3K, Akt and reactive oxygen species in DU145 human prostate carcinoma cells. Mol Cell Biochem 255: 33-45.
21. Skinner HD, Zhong XS, Gao N, Shi X, Jiang BH, (2004) Arsenic induces p70S6K1 activation and HIF-1alpha expression in prostate cancer cells. Mol Cell Biochem 255: 19-23.
22. Meng D, Wang X, Chang Q, Hitron A, Zhang Z, et al. (2010) Arsenic promotes angiogenesis in vitro via a heme oxygenase-1-dependent mechanism. Toxicol Appl. Pharmacol 244: 291-299.
23. Mousa SA, O'Connor L, Rossman TG, Block E, (2007) Pro-angiogenesis action of arsenic and its reversal by selenium-derived compounds. Carcinogenesis 28: 962-967.
24. Straub AC, Klei LR, Stolz DB, Barchowsky A, (2009) Arsenic requires sphingosine-1-phosphate type 1 receptors to induce angiogenic genes and endothelial cell remodeling. Am J Pathol 174: 1949-1958.
25. Jiang BH, Zheng JZ, Aoki M, Vogt PK, (2000) Phosphatidylinositol 3-kinase signaling mediates angiogenesis and expression of vascular endothelial growth factor in endothelial cells. Proc Natl Acad Sci U S A 97: 1749-1753.
26. Xia C, Meng Q, Liu LZ, Rojanasakul Y, Wang XR, et al. (2007) Reactive oxygen species regulate angiogenesis and tumor growth through vascular endothelial growth factor. Cancer Res 67: 10823-10830.
27. Liu LZ, Hu XW, Xia C, He J, Zhou Q, et al. (2006) Reactive oxygen species regulate epidermal growth factor-induced vascular endothelial growth factor and hypoxia-inducible factor-1alpha expression through activation of AKT and P70S6K1 in human ovarian cancer cells. Free Radic Biol Med 41: 1521-1533.
28. Semenza GL, (2003) Targeting HIF-1 for cancer therapy. Nat Rev Cancer 3: 721-732.
29. Forsythe JA, Jiang BH, Iyer NV, Agani F, Leung SW, et al. (1996) Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 16: 4604-4613.
30. Pi J, He Y, Bortner C, Huang J, Liu J, et al. (2005) Low level, long-term inorganic arsenic exposure causes generalized resistance to apoptosis in cultured human keratinocytes: potential role in skin co-carcinogenesis. Int J Cancer 116: 20-26.
31. Stohrer G, (1991) Arsenic: opportunity for risk assessment. Arch Toxicol 65: 525-531.
32. Ding W, Hudson LG, Liu KJ, (2005) Inorganic arsenic compounds cause oxidative damage to DNA and protein by inducing ROS and RNS generation in human keratinocytes. Mol Cell Biochem 279: 105-112.
33. Cooper KL, Liu KJ, Hudson LG, (2009) Enhanced ROS production and redox signaling with combined arsenite and UVA exposure: contribution of NADPH oxidase. Free Radic Biol Med 47: 381-388.
34. Sampayo-Reyes A, Hernandez A, El Yamani N, Lopez-Campos C, Mayet-Machado E, et al. (2010) Arsenic induces DNA damage in environmentally exposed Mexican children and adults. Influence of GSTO1 and AS3MT polymorphisms. Toxicol Sci 117: 63-71.
35. Connolly DT, Heuvelman DM, Nelson R, Olander JV, Eppley BL, et al. (1989) Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest 84: 1470-1478.
36. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N, (1989) Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246: 1306-1309.
37. Kim KJ, Li B, Winer J, Armanini M, Gillett N, et al. (1993) Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 362: 841-844.
38. Kierszniewska-Stepien D, Pietras T, Gorski P, Stepien H, (2006) Serum vascular endothelial growth factor and its receptor level in patients with chronic obstructive pulmonary disease. Eur Cytokine Netw 17: 75-79.
39. Yang Q, Underwood MJ, Hsin MK, Liu XC, He GW, (2008) Dysfunction of pulmonary vascular endothelium in chronic obstructive pulmonary disease: basic considerations for future drug development. Curr Drug Metab 9: 661-667.
40. Jatta K, Eliason G, Portela-Gomes GM, Grimelius L, Caro O, et al. (2009) Overexpression of von Hippel-Lindau protein in skeletal muscles of patients with chronic obstructive pulmonary disease. J Clin Pathol 62: 70-76.
41. Hasaneen NA, Zucker S, Lin RZ, Vaday GG, Panettieri RA, et al. (2007) Angiogenesis is induced by airway smooth muscle strain. Am J Physiol Lung Cell Mol Physiol 293: L1059-L1068.
42. Kamat CD, Green DE, Curilla S, Warnke L, Hamilton JW, et al. (2005) Role of HIF signaling on tumorigenesis in response to chronic low-dose arsenic administration. Toxicol. Sci. 86: 248-257.
43. Mottet D, Michel G, Renard P, Ninane N, Raes M, et al. (2003) Role of ERK and calcium in the hypoxia-induced activation of HIF-1. J Cell Physiol 194: 30-44.
44. Zhong H, Chiles K, Feldser D, Laughner E, Hanrahan C, et al. (2000) Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics. Cancer Res 60: 1541-1545.
45. Zhou Q, Liu LZ, Fu B, Hu X, Shi X, et al. (2007) Reactive oxygen species regulate insulin-induced VEGF and HIF-1alpha expression through the activation of p70S6K1 in human prostate cancer cells. Carcinogenesis 28: 28-37.